SMS Lifesciences India Limited
Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates
What SMS files
- Important30
- Others30
- Board Meeting6
- Dividend/Bonus2
- Updates2
- Credit Ratings1
SMS Lifesciences India Ltd. will soon be known as HALEOS LABS LIMITED, trading under the new symbol HALEOSLABS. This change is effective next week.
SMS Lifesciences India Limited has informed the Exchange about Copy of Newspaper Publication
Haleos Labs' board approved Q2/H1 FY26 consolidated financial results. Half-year revenue reached ₹163.87 Cr and Net Profit ₹10.81 Cr, with EPS at ₹33.93. The company confirmed its name change from SMS Lifesciences India.
Haleos Labs Limited (formerly SMS Lifesciences) has declared a ₹1.50 per share (15%) dividend for FY24-25. Payment is temporarily withheld for shareholders needing to update KYC or correct bank details. Update your information to receive the dividend.
Haleos Labs updated on its physical share transfer re-lodgment window. The company confirmed no requests were received, processed, approved, or rejected under this active opportunity for shareholders.